Icon

DEPACON (nda020593)- (EQ 100MG BASE/ML)

VALPROATE SODIUM ABBVIE
EQ 100MG BASE/ML
No No
Expired Expired
None None
None No
Depacon is indicated as an intravenous alternative in patients in whom oral administration of valproate products is temporarily not feasible in the following conditions: • Monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures.
4 0 3
Total Other Developers None
Drugs with Suitability No
EQ 100MG BASE/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
No 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* **** *** ********* **** ***, *** *********** **** ****** ****, ***** ******, *** **** (**) *****, ****** ****** (***) ***
****** ***** ************ ***** ************ (********), *.* *********** ******* *** ** **, */**/**, ******** ******, ****-***, ******** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.